Evenity Injection, Solution
Product Images NDC 55513-509
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Evenity (NDC 55513-509). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amgen, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Prepare And Clean Two Injection Sites, One For Each Of The Two Injections. See Figure B. (Evenity 02)
Figure C (Evenity 03)
Figure D (Evenity 04)
Principal Display Panelpdp Image And Text_evenity_pfs_ndc 55513-8802 X 105 mg/1.17 mL Singe-use Prefilled Syringendc 55513-880-02evenity™ (romosozumab-aqqg)injectionfor Healthcare Provider Use Only105 mg/1.17 mL + 105 mg/1.17 mL = 1 Dose 210 mg/2.34 mL2 X 105 mg/1.17 mL105 mg/1.17 mLfor Subcutaneous Use Onlysterile Solution – No Preservativestore Refrigerated At 2°c To 8°c (36°f To 46°f). Do Not Freeze Or Shake.store In Carton To Protect From Light.keep Out Of The Sight And Reach Of Children.attention: Provide The Enclose Medicationguide To Each Patient. For More Copiessee Evenity.com Or Call 1-800-77amgen.2 Syringes Must Be Administered Fora Full 210 mg/2.34 mL Doserx Onlyamgen® Ucb (Evenity 06)
This appears to be a description of a medication called "Evenity", specifically a single-use pre-filled syringe used for subcutaneous injection. It comes with a representative and should be stored in a refrigerator but not frozen or shaken. The label also includes various codes and identification numbers.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.